Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,654 public trials 851 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology

NCT02847130

Conditions
Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, +28 more
Locations
  • Kaiser Permanente-Oakland Oakland, California, United States
  • Alfred I duPont Hospital for Children Wilmington, Delaware, United States
  • Golisano Children's Hospital of Southwest Florida Fort Myers, Florida, United States
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida, United States
View all 33 locations
View Trial Details
Completed

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

NCT03028103

Conditions
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

NCT03364231

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details

Related conditions